Can PABA Really Restore Gray Hair?
There is a remarkable statistic that continues to appear in discussions about premature gray hair:
460 people with gray hair took 100 mg of PABA three times daily, and 82% reportedly experienced hair darkening within two to four months.
At first glance, that sounds like compelling clinical evidence.
But there is much more behind that number.
PABA para-aminobenzoic acid was investigated for hair repigmentation decades ago, long before the randomized, placebo-controlled clinical trials and standardized measurements we expect from modern research.
Some historical observations were intriguing. Others were inconsistent. And despite decades of progress in hair biology, PABA has not become an established treatment for gray hair.
So what did the original research actually find?
And why is the claim still being discussed today?
What Is PABA?
PABA stands for para-aminobenzoic acid.
You may sometimes see it marketed as "vitamin B10," although PABA is not recognized as an essential human vitamin in the same way as vitamin B12, folate or other established B vitamins.
PABA occurs naturally and is also involved in folate synthesis in certain microorganisms.
Its connection with gray hair comes largely from research conducted during the 1940s and mid-20th century, when researchers began reporting unexpected changes in hair pigmentation after PABA administration.
Those observations eventually became the foundation for one of the most repeated claims about supplements and gray hair.
Where Did the PABA and Gray-Hair Claim Begin?
One of the earliest documented investigations was published by Benjamin Sieve in 1941.
According to a 2020 systematic review of medication-induced gray-hair repigmentation, Sieve studied 50 people with premature or age-related gray hair who received 200 mg of PABA daily.
He reported subjective marked hair darkening in the participants after approximately two months.
This is important because it shows that interest in PABA and hair pigmentation wasn't created by modern supplement marketing.
There really were historical observations suggesting that PABA might influence hair color.
But those observations were made under research conditions very different from the standards used today.
What About the Famous 460-Person PABA Report?
A separate historical report is responsible for the statistic most commonly repeated today.
Later dermatology reviews describe a study involving 460 people with gray hair who received:
100 mg of PABA three times daily, for a total reported intake of 300 mg per day.
According to these reviews, hair darkening was reported in approximately 82% of participants, generally appearing within two to four months.
That's an extraordinary result.
It's also exactly the kind of statistic that can become misleading when separated from its historical context.
The evidence does not come from a modern large-scale randomized, double-blind, placebo-controlled trial.
There were also important limitations to what was reported.
The Hair Reportedly Became Gray Again After PABA Was Stopped
One of the most important details is often missing when the 82% statistic appears online.
The reported pigmentation wasn't necessarily permanent.
Reviews of the historical literature state that relapse occurred approximately two to four weeks after PABA was discontinued.
That raises an interesting biological question.
If the observation was genuine, was PABA temporarily influencing melanin production rather than permanently restoring the hair follicle's pigment-producing system?
Historical studies couldn't adequately answer that question.
The mechanism behind the reported darkening remains unclear.
And that is an important difference between observing a change and understanding why it happened.
Researchers Also Experimented With Much Higher Doses
Historical investigations didn't all use the same amount of PABA.
Another report by C.J.D. Zarafonetis described hair repigmentation during PABA therapy using doses reportedly ranging from approximately 12 to 20 grams per day.
Those amounts are dramatically higher than the frequently quoted 300 mg daily regimen.
This variation illustrates one of the problems with interpreting historical PABA evidence.
Different reports used different doses, populations and methodologies, making it difficult to determine whether there was a reliable dose-response relationship or which participants were most likely to respond.
Historical research doses also should not be interpreted as modern dosing recommendations.
Not Every PABA Study Produced Positive Results
Another historical experiment tested a combination containing PABA, calcium pantothenate and brewer's yeast for approximately eight months.
The researchers did not successfully restore pigmentation.
That negative result is important.
If PABA reliably restored gray hair, we would expect subsequent research to reproduce the effect consistently.
Instead, the historical literature contains both positive observations and unsuccessful attempts.
Modern reviews therefore describe these treatments cautiously rather than presenting PABA as an established therapy.
Why Does Hair Turn Gray?
The PABA question becomes much easier to understand once we look at the biology of hair pigmentation.
Hair color is produced inside the hair follicle.
Specialized pigment-producing cells called melanocytes create melanin during the active growth phase of the hair cycle. That pigment is transferred to cells that become part of the growing hair shaft.
When the pigmentary system stops functioning normally, less melanin reaches the growing hair.
The result is gray or eventually white hair.
But this isn't controlled by one nutrient or one molecule.
Modern research suggests that hair graying involves a complex combination of changes within the hair follicle.
Melanocyte Stem Cells Are an Important Part of the Story
Researchers are particularly interested in melanocyte stem cells.
These stem cells help maintain the population of pigment-producing melanocytes needed during successive hair-growth cycles.
As the pigmentation system becomes disrupted, the follicle can progressively lose functional melanocytes and their progenitor cells.
A major 2024 review in the Journal of Investigative Dermatology describes hair graying as involving several interacting processes, including cumulative oxidative and DNA damage, melanocyte senescence, altered cellular signaling, reduced melanogenesis and eventual depletion of cells involved in the hair-follicle pigmentary system.
Importantly, the researchers note that graying may not become biologically irreversible until certain melanocyte stem-cell populations are also depleted.
PMID: 38099887
This is one reason gray-hair research has moved far beyond the idea that graying simply means the hair has "run out of pigment."
What Can Contribute to Premature Gray Hair?
Premature graying does not have one universal cause.
Genetics is one of the most important factors. If close family members developed gray hair relatively early, genetic influences may contribute to a similar pattern.
Researchers are also studying oxidative stress. Pigment-producing cells within the hair follicle are exposed to reactive molecules that can damage cellular structures, and changes in antioxidant defenses may contribute to dysfunction of the follicular pigmentation system.
Nutritional status can matter in some individuals as well. Research has reported associations between premature graying and abnormalities involving nutrients such as vitamin B12, folate, iron-related markers and certain minerals. However, an association does not mean that taking a supplement will restore hair color in someone who isn't deficient.
Smoking has also been associated with premature graying in observational studies, while certain thyroid, autoimmune and other medical conditions may sometimes be relevant.
The key point is that premature gray hair is multifactorial.
Two people can develop gray hair at the same age for very different biological reasons.
Could Gray Hair Ever Regain Pigment?
Interestingly, researchers now know that gray hair isn't necessarily irreversible in every circumstance.
Cases of spontaneous and medication-associated hair repigmentation have been documented.
A 2020 systematic review identified 27 studies discussing medication-associated repigmentation of gray hair. The interventions ranged from anti-inflammatory medications and compounds affecting melanogenesis to vitamin-related approaches including PABA and calcium pantothenate.
However, the authors characterized the evidence for vitamin B-complex approaches as low quality and noted that the compounds reviewed were not established treatments for gray hair.
PMID: 32021854
Modern hair biology also suggests that reversibility may depend partly on how far the follicle's pigmentation system has deteriorated.
A follicle that still contains viable melanocytes or melanocyte progenitor cells is biologically different from one in which critical pigment-producing cell populations have been depleted.
That may eventually help explain why repigmentation appears possible in some circumstances but not others.
So What Does Modern Evidence Say About PABA?
The historical evidence gives researchers a reason to remain curious about PABA.
It does not give us strong evidence that PABA is a proven treatment for premature gray hair.
The distinction matters.
Historical reports described hair darkening after PABA administration, including the widely cited observation involving 460 people.
But modern reviews point to major evidence gaps.
We still lack strong contemporary randomized controlled trials that independently reproduce the historical findings using standardized hair-pigmentation measurements.
The mechanism remains unclear.
The optimal dose is not established.
We don't know which people, if any, are most likely to respond.
We don't know whether nutritional status influenced the historical observations.
And the durability of the reported effect is questionable because graying reportedly returned after supplementation stopped.
The evidence is therefore better described as historically interesting but clinically unconfirmed.
What the Famous 82% Statistic Does and Does Not Tell Us
The statistic shouldn't simply be dismissed.
Historical dermatology literature really does describe a report in which 82% of 460 gray-haired individuals experienced hair darkening after taking 100 mg of PABA three times daily for two to four months.
But that observation does not establish that PABA reverses gray hair in 82% of people today.
It does not prove permanent repigmentation.
It does not establish an appropriate modern treatment dose.
It does not tell us whether participants had nutritional deficiencies or other factors that influenced their response.
And it does not establish that PABA can restore melanocyte stem cells or reverse the biological processes responsible for age-related graying.
Those questions require much stronger evidence.
What Would a Modern PABA Trial Need to Show?
If researchers wanted to properly test the historical claim today, the study would look very different.
Participants would ideally be randomized to PABA or placebo. Researchers would define whether participants had premature or typical age-related graying, document their nutritional and medical status, use standardized photography or objective pigmentation measurements, and follow them for a meaningful period.
Researchers would also need to determine whether any new pigmentation occurred in the newly growing portion of individual hair shafts.
And if pigmentation did return, the next question would be even more interesting:
What changed inside the follicle?
Did melanocytes begin producing more melanin?
Did melanocyte progenitor cells become more active?
Did oxidative stress change?
Did the intervention affect another pathway entirely?
Finally, participants would need follow-up after treatment stopped to determine whether any effect persisted.
Until research like this is performed and independently replicated, the historical PABA findings remain an intriguing hypothesis rather than a settled answer.
Why This Research Still Matters
PABA may or may not eventually prove important to modern gray-hair research.
But the historical observations point toward something broader.
Hair pigmentation may be more biologically dynamic than scientists once assumed.
The discovery that certain medications, hormones and biological conditions can sometimes be associated with repigmentation suggests that the hair follicle retains pigmentation capacity under some circumstances.
Modern researchers are now investigating the cellular machinery behind that possibility rather than relying solely on historical supplementation observations.
That includes melanocyte stem cells, oxidative stress, cellular senescence, signaling pathways, the hair cycle and the follicular microenvironment.
Understanding those mechanisms may ultimately prove more valuable than simply asking whether one compound can "reverse gray hair."
Explore the Gray-Hair Research First
If you're interested in PABA because you've seen claims that it restores gray hair, the best place to start is the evidence.
The historical observations are worth understanding, but they should be considered alongside what modern researchers now know about melanocytes, melanocyte stem cells, oxidative stress, genetics and the biology of the human hair follicle.
Aeternum's hair-pigmentation research content explores these topics without treating an early observation as a proven modern treatment.
Explore Aeternum's Gray Hair & Pigmentation Research
Optional: Where Silver Reverse™ Fits
For readers interested in moving from research into product exploration, Aeternum's Silver Reverse™ system should be considered separately from the historical PABA studies.
The Silver Reverse™ Hair Serum contains cosmetic ingredients including Palmitoyl Tetrapeptide-20 Amide, Copper Tripeptide-1, Biotinyl Tripeptide-1, Niacinamide, Gallic Acid and Polygonum Multiflorum Root Extract.
These ingredients are selected in the context of hair and scalp support and research relating to hair appearance and follicle biology.
Importantly, research on PABA does not prove that Silver Reverse™ will reproduce historical PABA results, and the product should not be presented as a proven treatment for reversing gray hair.
Instead, readers interested in the product can examine its formulation, ingredients and available supporting information separately.
Explore Silver Reverse™ product information
Research first. Product information second. That makes it easier to distinguish what scientists have actually observed from what still remains under investigation.
The Bottom Line
The PABA and gray-hair story is based on real historical observations but the evidence is far less definitive than the viral statistic makes it sound.
Researchers reported hair darkening after PABA supplementation decades ago. One frequently cited report involved 460 people taking 100 mg three times daily, with pigmentation reportedly returning in 82% within two to four months.
But the effect reportedly reversed after PABA was discontinued, other historical experiments produced inconsistent results, and modern controlled trials have not established PABA as a reliable treatment for premature gray hair.
Meanwhile, our understanding of hair graying has changed dramatically.
Scientists now view graying as a complex biological process involving melanocytes, melanocyte stem cells, genetics, oxidative and DNA damage, cellular signaling, senescence and the changing environment of the aging hair follicle.
So the most interesting question isn't simply:
"Does PABA reverse gray hair?"
It's:
"Why did some historical researchers observe repigmentation at all and what can that teach us about how human hair pigmentation is controlled?"
That question remains open.
And that's what makes the research worth following.
Research Featured in This Article
Yale K, Juhasz M, Atanaskova Mesinkovska N. (2020).
Medication-Induced Repigmentation of Gray Hair: A Systematic Review.
Skin Appendage Disorders. PMID: 32021854. PMCID: PMC6995950.
This systematic review examines historical and modern reports of medication-associated gray-hair repigmentation, including early PABA research. It describes the evidence surrounding vitamin-related interventions as low quality.
Poonia K, Bhalla M. (2024).
Premature Graying of Hair: A Comprehensive Review and Recent Insights.
This review discusses historical PABA research, including the frequently cited report of 460 people receiving 100 mg three times daily and the reported return of graying after discontinuation.
Paus R, Sevilla A, Grichnik JM. (2024).
Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers.
Journal of Investigative Dermatology. PMID: 38099887.
This modern review examines the biology of human hair graying, including melanocyte senescence, oxidative and DNA damage, melanogenesis, hair-follicle pigmentation and melanocyte stem-cell depletion.